Relationship between female dyslipidemia and polymorphism of suppressor of cytokine signaling-3 in Xinjiang Uygur population

Acta Academiae Medicinae Sinicae

Volumn 36, Issue 1, 2014, Pages 5-11

  Meng, Jing ^a   Li, Nan Fang ^b   Yao, Xiao Guang ^b   Shao, Liang ^b   Zhou, Ling ^b   Arikin, Abdurmy ^b   Zhang, Jing Jing ^b  

^a SHIHEZI UNIVERSITY   (China)

^b PEOPLE S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION   (China)

Author keywords

Dyslipidemia; Leptin; Suppressor of cytokine signaling 3

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRIACYLGLYCEROL; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; BODY MASS; CORRELATIONAL STUDY; DISEASE PREDISPOSITION; DYSLIPIDEMIA; FEMALE; FREQUENCY ANALYSIS; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; EPIDEMIOLOGY; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; MALE; MIDDLE AGED;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84897135767     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2014.01.002     Document Type: Article

References (26)

1. Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome-a new worldwide definition [J]. Lancet, 2005, 366(9491):1059-1062. (Pubitemid 41338752)
2. Nanfang L, Yanying G, Hongmei W, et al. Variations of six transmembrane epithelial antigen of prostate 4 (STEAP4) gene are associated with metabolic syndrome in a female Uygur general population [J]. Arch Med Res, 2010, 41(6):449-456.
3. Yao XG, Frommlet F, Zhou L, et al. The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang [J]. BMC Public Health, 2010, 10:91.
4. Endo TA, Masuhara M, Yokouchi M, et al. A new protein containing an sh2 domain that inhibits JAK kinases [J]. Nature, 1997, 387(6636):921-924. (Pubitemid 27289595)
5. Qin H, Holdbrooks AT, Liu Y, et al. SOCS-3 deficiency promotes M1 macrophage polarization and inflammation [J]. J Immunol, 2012, 189(7):3439-3448.
6. Jorqensen SB, O'Neil HM, Sylow L, et al. Deletion of skeletal muscle SOCS-3 prevents insulin resistance in obesity [J]. Diabetes, 2013, 61(1):56-64.
7. Gu H, Liu L, Ma S, et al. Inhibition of SOCS-3 in adipocytes of rats with diet-induced obesity increase leptin-mediated fatty acid oxidation [J]. Endocrine, 2009, 36(3):546-554.
8. Ueki K, Kadowaki T, Kahn CR. Role of suppressor of cytokine signaling SOCS-1 and SOCS-3 in hepatic and the metabolic syndrome [J]. Hepatol Res, 2005, 33(2):185-192. (Pubitemid 41799802)
9. Hǒlter K, Wermter AK, Scherag A, et al. Analysis of sequence variations in the suppressor of cytokine signaling (SOCS-3) gene in extremely obese children and adolescents [J]. BMC Med Genet, 2007, 8(21):1-6.
10. Tang W, Zou JJ, Chen XF, et al. Association of two polymorphisms within and near SOCS-3 gene with obesity in three nationalities in Xinjiang province of China [J]. Acta Pharmacol Sin, 2011, 32(11):1381-1386.
11. Talbert ME, Langefeld CD, Ziegler J, et al. Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the insulin resistance atherosclerosis family study [J]. Hum Genet, 2009, 125(2):153-162.
12. Reaven GM, Chen YD, Jeppesen J, et al. Insulin resistence and hyperinsulinemia in individuals with small, dense low density lipoprotein particles [J]. J Clin Invest, 1993, 92(1):141-146. (Pubitemid 23208989)
13. Tall AR. Plasma cholesterol ester transfer protein [J]. J Lipid Res, 1993, 34(8):1255-1274. (Pubitemid 23230305)
14. Caprio S. Relationship between abdominal visceral fat and metabolic risk factors in obese adolescents [J]. Am J Hum Biol, 1999, 11(2):259-266. (Pubitemid 129726295)
15. Wang Z, Zhou YT, Kakuma T, et al. Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling [J]. Biochem Biophys Res Commun, 2000, 277(1):20-26.
16. Gotto AM. Postmenopausal hormone-replacement therapy, plasma lipoprotein [a], and risk for coronary heart disease (editorial) [J]. J Lab Clin Med, 1994, 123(6):727-733.
17. Matusubara Y, Murata M, Kawano K, et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal woman from healthy and coronary populations and its relation to serum lipid levels [J]. Arterioscler Thromb Vasc Biol, 1997, 17(11):3006-3012. (Pubitemid 28016053)